id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT01980043 | 1:71:treatment | Previous Abdominal Surgeries including abdominal wall repair with mesh | 2 | [
"Previous",
"Abdominal",
"Surgeries",
"including",
"abdominal",
"wall",
"repair",
"with",
"mesh"
] | [
1,
1,
1,
1,
1,
1,
1,
1,
1
] |
NCT02747888 | 70:84:cancer | Individual adult patient with current or previous known or suspected thyroid cancer or nodule(s) if they come from a family with a high suspicion of hereditary cancer | 2 | [
"Individual",
"adult",
"patient",
"with",
"current",
"or",
"previous",
"known",
"or",
"suspected",
"thyroid",
"cancer",
"or",
"nodule",
"(",
"s",
")",
"if",
"they",
"come",
"from",
"a",
"family",
"with",
"a",
"high",
"suspicion",
"of",
"hereditary",
"cancer"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02807883 | 15:24:cancer | Patients with B-lineage | 2 | [
"Patients",
"with",
"B-lineage"
] | [
0,
0,
3
] |
NCT02352467 | 18:38:chronic_disease | Subjects who are cognitively impaired | 2 | [
"Subjects",
"who",
"are",
"cognitively",
"impaired"
] | [
0,
0,
0,
2,
2
] |
NCT02230605 | 9:33:treatment | Planned postoperative intubation | 2 | [
"Planned",
"postoperative",
"intubation"
] | [
0,
1,
1
] |
NCT02589977 | 21:23:chronic_disease | acute decompensated HF | 2 | [
"acute",
"decompensated",
"HF"
] | [
0,
0,
2
] |
NCT01624090 | 1:13:treatment | Dipyridamole | 2 | [
"Dipyridamole"
] | [
1
] |
NCT01553214 | 21:41:chronic_disease | Active, symptomatic peptic ulcer disease | 2 | [
"Active",
",",
"symptomatic",
"peptic",
"ulcer",
"disease"
] | [
0,
0,
0,
2,
2,
2
] |
NCT02163317 | 1:38:chronic_disease,61:80:chronic_disease,121:134:treatment | Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy at the time of registration | 2 | [
"Chronic",
"obstructive",
"pulmonary",
"disease",
"exacerbation",
"or",
"other",
"respiratory",
"illness",
"requiring",
"hospitalization",
"or",
"precluding",
"study",
"therapy",
"at",
"the",
"time",
"of",
"registration"
] | [
2,
2,
2,
2,
0,
0,
0,
2,
2,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02186418 | 21:41:treatment,55:61:chronic_disease,67:92:chronic_disease,228:251:treatment | Patients who are on chronic transfusions for clinical stroke with MRA cerebral vasculopathy will be excluded since patients in the SWITCH study who were randomized to the hydroxyurea arm had recurrent stroke, while none in the chronic transfusion arm | 2 | [
"Patients",
"who",
"are",
"on",
"chronic",
"transfusions",
"for",
"clinical",
"stroke",
"with",
"MRA",
"cerebral",
"vasculopathy",
"will",
"be",
"excluded",
"since",
"patients",
"in",
"the",
"SWITCH",
"study",
"who",
"were",
"randomized",
"to",
"the",
"hydroxyur... | [
0,
0,
0,
0,
1,
1,
1,
0,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03146663 | 57:84:treatment | Disease that progressed while receiving initial line of platinum-based chemotherapy | 2 | [
"Disease",
"that",
"progressed",
"while",
"receiving",
"initial",
"line",
"of",
"platinum-based",
"chemotherapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02087826 | 31:44:chronic_disease,56:70:chronic_disease,101:123:treatment | Conditions causing intestinal malabsorption, including celiac disease or a history of intestinal or gastric bypass surgery | 2 | [
"Conditions",
"causing",
"intestinal",
"malabsorption",
",",
"including",
"celiac",
"disease",
"or",
"a",
"history",
"of",
"intestinal",
"or",
"gastric",
"bypass",
"surgery"
] | [
0,
0,
0,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT02421315 | 27:40:treatment | Positive urine screen for illicit drugs | 2 | [
"Positive",
"urine",
"screen",
"for",
"illicit",
"drugs"
] | [
0,
0,
0,
0,
1,
1
] |
NCT01878617 | ,,,,214:233:cancer | Age greater than or equal to 3 years and less than 22 years of age at the time of diagnosis (may enroll on Strata W, S or N), OR (2) age is greater than or equal to 22 years and less than 40 years AND patient has SHH medulloblastoma (must enroll on Stratum S) | 2 | [
"Age",
"greater",
"than",
"or",
"equal",
"to",
"3",
"years",
"and",
"less",
"than",
"22",
"years",
"of",
"age",
"at",
"the",
"time",
"of",
"diagnosis",
"(",
"may",
"enroll",
"on",
"Strata",
"W",
",",
"S",
"or",
"N",
")",
",",
"OR",
"(",
"2",
")",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02106598 | 1:16:chronic_disease | unstable angina | 2 | [
"unstable",
"angina"
] | [
2,
2
] |
NCT03027388 | 16:21:treatment,,,,,,,,, | The effects of LB100 on the developing human fetus are unknown. For this reason, women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation. Should a woman become pregnant or... | 2 | [
"The",
"effects",
"of",
"LB100",
"on",
"the",
"developing",
"human",
"fetus",
"are",
"unknown",
".",
"For",
"this",
"reason",
",",
"women",
"of",
"child-bearing",
"potential",
"and",
"men",
"must",
"agree",
"to",
"use",
"adequate",
"contraception",
"(",
"hor... | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT01666665 | 1:26:chronic_disease | Acute or chronic acidosis (lactic or any other metabolic type) | 2 | [
"Acute",
"or",
"chronic",
"acidosis",
"(",
"lactic",
"or",
"any",
"other",
"metabolic",
"type",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02266719 | 1:26:chronic_disease,99:137:treatment,141:160:treatment | Thoracic aortic aneurysms that extend into the arch, with the exception of those patients who had prior open surgical aortic replacement or endovascular repair, where a surgical graft or an endograft has been extended proximal and/or near the celiac artery (functional type IV) that would serve as landing zone for the i... | 2 | [
"Thoracic",
"aortic",
"aneurysms",
"that",
"extend",
"into",
"the",
"arch",
",",
"with",
"the",
"exception",
"of",
"those",
"patients",
"who",
"had",
"prior",
"open",
"surgical",
"aortic",
"replacement",
"or",
"endovascular",
"repair",
",",
"where",
"a",
"surg... | [
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03040726 | 1:21:treatment,23:30:treatment,32:48:treatment,54:70:treatment,, | Total (T.) bilirubin, albumin, prothrombin time, and serum creatinine tests can be done within 14 days of study enrollment (only if not performed in the last 14 days) | 2 | [
"Total",
"(",
"T.",
")",
"bilirubin",
",",
"albumin",
",",
"prothrombin",
"time",
",",
"and",
"serum",
"creatinine",
"tests",
"can",
"be",
"done",
"within",
"14",
"days",
"of",
"study",
"enrollment",
"(",
"only",
"if",
"not",
"performed",
"in",
"the",
"l... | [
1,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02663908 | 1:29:chronic_disease, | Acute cardiovascular disease in the previous 30 days | 2 | [
"Acute",
"cardiovascular",
"disease",
"in",
"the",
"previous",
"30",
"days"
] | [
2,
2,
2,
0,
0,
0,
0,
0
] |
NCT02524379 | 26:43:chronic_disease, | Unconsciousness or other mental impairment that prevents neurological assessment within the first 8 hours | 2 | [
"Unconsciousness",
"or",
"other",
"mental",
"impairment",
"that",
"prevents",
"neurological",
"assessment",
"within",
"the",
"first",
"8",
"hours"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03165227 | 1:10:treatment,16:32:treatment,40:68:treatment,70:78:treatment,82:91:treatment | Treatment with SGLT2 inhibitors and/or phosphodiesterase inhibitors, nitrates or riociguat, from screening (Visit 1) or within 5 half-lives before randomisation whatever is earlier | 2 | [
"Treatment",
"with",
"SGLT2",
"inhibitors",
"and/or",
"phosphodiesterase",
"inhibitors",
",",
"nitrates",
"or",
"riociguat",
",",
"from",
"screening",
"(",
"Visit",
"1",
")",
"or",
"within",
"5",
"half-lives",
"before",
"randomisation",
"whatever",
"is",
"earlier"... | [
1,
0,
1,
1,
0,
1,
1,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02577406 | 27:80:treatment,86:90:treatment,92:103:treatment,107:117:treatment | Refractory to or relapsed after second- or third-line low-intensity AML therapy (eg, LDAC, azacitidine or decitabine) | 2 | [
"Refractory",
"to",
"or",
"relapsed",
"after",
"second-",
"or",
"third-line",
"low-intensity",
"AML",
"therapy",
"(",
"eg",
",",
"LDAC",
",",
"azacitidine",
"or",
"decitabine",
")"
] | [
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
0,
1,
0
] |
NCT02101554 | ,53:70:chronic_disease | Columbia-Suicide Severity Rating Scale (C-SSRS) for suicidal ideation and behavior in past year | 2 | [
"Columbia-Suicide",
"Severity",
"Rating",
"Scale",
"(",
"C-SSRS",
")",
"for",
"suicidal",
"ideation",
"and",
"behavior",
"in",
"past",
"year"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02555280 | 20:43:treatment,112:120:treatment,139:155:treatment | Chronically taking medications or any drug known to potentially interfere with bone/soft tissue healing (e.g., steroids), not including a medrol dose pack | 2 | [
"Chronically",
"taking",
"medications",
"or",
"any",
"drug",
"known",
"to",
"potentially",
"interfere",
"with",
"bone/soft",
"tissue",
"healing",
"(",
"e.g.",
",",
"steroids",
")",
",",
"not",
"including",
"a",
"medrol",
"dose",
"pack"
] | [
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
1,
1,
1
] |
NCT01584076 | 16:26:treatment,35:44:treatment,48:52:chronic_disease,56:79:chronic_disease | Current use of medication for the treatment of ADHD or psychological disorders | 2 | [
"Current",
"use",
"of",
"medication",
"for",
"the",
"treatment",
"of",
"ADHD",
"or",
"psychological",
"disorders"
] | [
0,
0,
0,
1,
0,
0,
1,
0,
2,
0,
2,
2
] |
NCT02250157 | 77:93:chronic_disease,107:131:chronic_disease,133:154:chronic_disease,,181:205:chronic_disease,207:225:chronic_disease,227:252:chronic_disease,277:295:chronic_disease | Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, myocardial infarction within the last 6 months, unstable angina pectoris, cardiac arrhythmia, chronic pulmonary disease requiring oxygen, known bleeding disorders, or any concomitant illne... | 2 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
",",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"myocardial",
"infarction",
"within",
"the",
"last",
"6",
"months",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02798458 | 21:28:chronic_disease | Previous history of bezoars | 2 | [
"Previous",
"history",
"of",
"bezoars"
] | [
0,
0,
0,
2
] |
NCT01817751 | 7:29:chronic_disease | Known mitochondrial disorder caused by mutations in mitochondrial DNA polymerase γ | 2 | [
"Known",
"mitochondrial",
"disorder",
"caused",
"by",
"mutations",
"in",
"mitochondrial",
"DNA",
"polymerase",
"γ"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01976169 | 1:6:cancer,15:19:cancer,33:35:treatment | Tumor must be HER2-positive and RB-proficient | 2 | [
"Tumor",
"must",
"be",
"HER2-positive",
"and",
"RB-proficient"
] | [
3,
0,
0,
3,
0,
1
] |
NCT03077412 | 12:33:treatment,35:50:treatment,64:73:treatment,77:86:treatment,114:121:treatment | History of total proctocolectomy, total colectomy, presence of ileostomy or colostomy, or likely requirement for surgery during the study | 2 | [
"History",
"of",
"total",
"proctocolectomy",
",",
"total",
"colectomy",
",",
"presence",
"of",
"ileostomy",
"or",
"colostomy",
",",
"or",
"likely",
"requirement",
"for",
"surgery",
"during",
"the",
"study"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT03028350 | 12:57:treatment,88:109:treatment,,148:157:treatment | Any use of nonsteroidal anti-inflammatory drugs (NSAIDs) or any drug that inhibits the cyclooxygenase enzyme in the last two weeks before starting treatment | 2 | [
"Any",
"use",
"of",
"nonsteroidal",
"anti-inflammatory",
"drugs",
"(",
"NSAIDs",
")",
"or",
"any",
"drug",
"that",
"inhibits",
"the",
"cyclooxygenase",
"enzyme",
"in",
"the",
"last",
"two",
"weeks",
"before",
"starting",
"treatment"
] | [
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02639065 | 20:59:treatment,52:59:treatment,69:94:treatment, | Patients receiving chronic systemic corticosteroid therapy or other immunosuppressive therapy within 28 days prior to registration for protocol therapy | 2 | [
"Patients",
"receiving",
"chronic",
"systemic",
"corticosteroid",
"therapy",
"or",
"other",
"immunosuppressive",
"therapy",
"within",
"28",
"days",
"prior",
"to",
"registration",
"for",
"protocol",
"therapy"
] | [
0,
0,
1,
1,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02373644 | 8:20:chronic_disease | severe osteoporosis | 2 | [
"severe",
"osteoporosis"
] | [
0,
2
] |
NCT02463305 | 24:39:chronic_disease | Evidence or history of toxic megacolon | 2 | [
"Evidence",
"or",
"history",
"of",
"toxic",
"megacolon"
] | [
0,
0,
0,
0,
2,
2
] |
NCT03121586 | 1:11:treatment | Lurasidone | 2 | [
"Lurasidone"
] | [
1
] |
NCT02477839 | 19:35:chronic_disease | The occurrence of febrile seizures in addition to partial-onset seizures | 2 | [
"The",
"occurrence",
"of",
"febrile",
"seizures",
"in",
"addition",
"to",
"partial-onset",
"seizures"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02245841 | 15:27:chronic_disease | Patients with osteoporosis | 2 | [
"Patients",
"with",
"osteoporosis"
] | [
0,
0,
2
] |
NCT02403128 | 13:27:chronic_disease | Concomitant ocular disease that can cause increase in foveal thickness | 2 | [
"Concomitant",
"ocular",
"disease",
"that",
"can",
"cause",
"increase",
"in",
"foveal",
"thickness"
] | [
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02481245 | 45:66:treatment, | Taking an adequate dose of any FDA-approved anti-manic medication for at least two weeks prior to enrollment | 2 | [
"Taking",
"an",
"adequate",
"dose",
"of",
"any",
"FDA-approved",
"anti-manic",
"medication",
"for",
"at",
"least",
"two",
"weeks",
"prior",
"to",
"enrollment"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02584647 | ,,53:60:treatment,65:74:treatment,109:120:treatment,124:137:treatment | Pregnant women are excluded from this study because PLX3397 and sirolimus are agents with the potential for teratogenic or abortifacient effects | 2 | [
"Pregnant",
"women",
"are",
"excluded",
"from",
"this",
"study",
"because",
"PLX3397",
"and",
"sirolimus",
"are",
"agents",
"with",
"the",
"potential",
"for",
"teratogenic",
"or",
"abortifacient",
"effects"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0
] |
NCT01059786 | 1:17:chronic_disease,, | Thrombocytopenia (Plt less than 100,000/microl) | 2 | [
"Thrombocytopenia",
"(",
"Plt",
"less",
"than",
"100,000/microl",
")"
] | [
2,
0,
0,
0,
0,
0,
0
] |
NCT01624090 | 1:14:treatment | Valproic acid | 2 | [
"Valproic",
"acid"
] | [
1,
1
] |
NCT02392572 | 41:79:cancer,64:79:cancer,83:96:cancer | For Arm E, in addition to patients with relapsed or refractory acute leukemias or high-risk MDS, patients with untreated high-risk MDS or acute leukemias | 2 | [
"For",
"Arm",
"E",
",",
"in",
"addition",
"to",
"patients",
"with",
"relapsed",
"or",
"refractory",
"acute",
"leukemias",
"or",
"high-risk",
"MDS",
",",
"patients",
"with",
"untreated",
"high-risk",
"MDS",
"or",
"acute",
"leukemias"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02520011 | ,32:49:treatment,54:57:cancer,59:81:treatment,93:111:treatment,185:196:treatment | Received more than 2 cycles of induction therapy for AML. Investigational agents as part of front-line therapy for AML may by acceptable following discussion with the Medical Monitor. Hydroxyurea is permitted (see #5 below) | 2 | [
"Received",
"more",
"than",
"2",
"cycles",
"of",
"induction",
"therapy",
"for",
"AML",
".",
"Investigational",
"agents",
"as",
"part",
"of",
"front-line",
"therapy",
"for",
"AML",
"may",
"by",
"acceptable",
"following",
"discussion",
"with",
"the",
"Medical",
... | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
3,
0,
1,
1,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03085433 | ,26:45:chronic_disease | Male partner with severe oligoasthenospermia | 2 | [
"Male",
"partner",
"with",
"severe",
"oligoasthenospermia"
] | [
0,
0,
0,
0,
2
] |
NCT01937884 | 9:29:treatment | Require artificial nutrition | 2 | [
"Require",
"artificial",
"nutrition"
] | [
0,
1,
1
] |
NCT02579265 | 1:15:chronic_disease | Meconium ileus | 2 | [
"Meconium",
"ileus"
] | [
2,
2
] |
NCT02921022 | 30:47:treatment,, | Patients with current use of megestrol acetate (use with 10 days of Day 1) | 2 | [
"Patients",
"with",
"current",
"use",
"of",
"megestrol",
"acetate",
"(",
"use",
"with",
"10",
"days",
"of",
"Day",
"1",
")"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02505165 | 32:38:cancer | The child is being treated for cancer and returning to the medical center (CCHMC or OUHSC) | 2 | [
"The",
"child",
"is",
"being",
"treated",
"for",
"cancer",
"and",
"returning",
"to",
"the",
"medical",
"center",
"(",
"CCHMC",
"or",
"OUHSC",
")"
] | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02508038 | 1:12:chronic_disease | Hepatitis C antibody (Anti-HCV) | 2 | [
"Hepatitis",
"C",
"antibody",
"(",
"Anti-HCV",
")"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02908841 | 1:43:treatment | robotic assisted laparoscopic hysterectomy | 2 | [
"robotic",
"assisted",
"laparoscopic",
"hysterectomy"
] | [
1,
1,
1,
1
] |
NCT01730118 | ,,,,,,,220:238:cancer | Chemistry parameters: Creatinine less than mg/dL, SGOT and SGPT less than or equal to 3X ULN, total bilirubin less than or equal to 1.5X ULN and Alk PO4 less than or equal to 3X ULN (except for patients with documented metastatic disease to bone and/or liver) | 2 | [
"Chemistry",
"parameters",
":",
"Creatinine",
"less",
"than",
"mg/dL",
",",
"SGOT",
"and",
"SGPT",
"less",
"than",
"or",
"equal",
"to",
"3X",
"ULN",
",",
"total",
"bilirubin",
"less",
"than",
"or",
"equal",
"to",
"1.5X",
"ULN",
"and",
"Alk",
"PO4",
"less... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0
] |
NCT02478684 | 1:14:chronic_disease | Cord prolapse | 2 | [
"Cord",
"prolapse"
] | [
2,
2
] |
NCT01754298 | 14:33:chronic_disease | Diagnosis of sickle cell disease | 2 | [
"Diagnosis",
"of",
"sickle",
"cell",
"disease"
] | [
0,
0,
2,
2,
2
] |
NCT03082157 | 24:31:chronic_disease, | Participant in another obesity, eating or physical activity program or study -Psychiatric hospitalization in the past 12 months | 2 | [
"Participant",
"in",
"another",
"obesity",
",",
"eating",
"or",
"physical",
"activity",
"program",
"or",
"study",
"-Psychiatric",
"hospitalization",
"in",
"the",
"past",
"12",
"months"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01880567 | 17:20:chronic_disease,28:31:chronic_disease,64:75:chronic_disease | Newly diagnosed MCL: Known HIV infection; patients with active hepatitis B infection | 2 | [
"Newly",
"diagnosed",
"MCL",
":",
"Known",
"HIV",
"infection",
";",
"patients",
"with",
"active",
"hepatitis",
"B",
"infection"
] | [
0,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0,
2,
2,
0
] |
NCT02152995 | ,,69:82:treatment | patients with controlled atrial fibrillation for > 30 days prior to randomization | 2 | [
"patients",
"with",
"controlled",
"atrial",
"fibrillation",
"for",
">",
"30",
"days",
"prior",
"to",
"randomization"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT01793519 | 14:22:treatment,24:33:treatment,38:49:treatment, | Treated with anakinra, abatacept, or tocilizumab in the last 6 months | 2 | [
"Treated",
"with",
"anakinra",
",",
"abatacept",
",",
"or",
"tocilizumab",
"in",
"the",
"last",
"6",
"months"
] | [
0,
0,
1,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT03146663 | 1:19:treatment,21:30:treatment,107:121:treatment,123:137:treatment,141:154:treatment, | Prior chemotherapy, radiation (other than short cycle of radiation to reduce bone pain), treatment with a VEGF inhibitor, PARP inhibitor or immunotherapy within 21 days of first receipt of study drug | 2 | [
"Prior",
"chemotherapy",
",",
"radiation",
"(",
"other",
"than",
"short",
"cycle",
"of",
"radiation",
"to",
"reduce",
"bone",
"pain",
")",
",",
"treatment",
"with",
"a",
"VEGF",
"inhibitor",
",",
"PARP",
"inhibitor",
"or",
"immunotherapy",
"within",
"21",
"d... | [
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01312857 | 35:46:chronic_disease,48:49:chronic_disease,51:52:chronic_disease,58:74:chronic_disease | Patients with current evidence of hepatitis A, B, C (ie, active hepatitis) | 2 | [
"Patients",
"with",
"current",
"evidence",
"of",
"hepatitis",
"A",
",",
"B",
",",
"C",
"(",
"ie",
",",
"active",
"hepatitis",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
0,
0,
2,
2,
0
] |
NCT02982226 | 18:29:treatment | has receive such medications during the screening period | 2 | [
"has",
"receive",
"such",
"medications",
"during",
"the",
"screening",
"period"
] | [
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02811679 | 25:40:treatment,33:40:treatment,,,139:200:treatment | Subjects who respond to initial therapy for greater than one year must have had at least 2 prior lines of therapy including one line with chemoimmunotherapy including an anti-CD20 monoclonal antibody | 2 | [
"Subjects",
"who",
"respond",
"to",
"initial",
"therapy",
"for",
"greater",
"than",
"one",
"year",
"must",
"have",
"had",
"at",
"least",
"2",
"prior",
"lines",
"of",
"therapy",
"including",
"one",
"line",
"with",
"chemoimmunotherapy",
"including",
"an",
"anti-... | [
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT02256631 | 21:40:treatment,,117:122:treatment,124:131:treatment,136:141:treatment,142:147:treatment | Any requirement for supplemental oxygen beyond 24 hours of life or requiring supplemental oxygen at the time of the VRC01, VRC01LS, or VRC07-523LS dose | 2 | [
"Any",
"requirement",
"for",
"supplemental",
"oxygen",
"beyond",
"24",
"hours",
"of",
"life",
"or",
"requiring",
"supplemental",
"oxygen",
"at",
"the",
"time",
"of",
"the",
"VRC01",
",",
"VRC01LS",
",",
"or",
"VRC07-523LS",
"dose"
] | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
0
] |
NCT02393690 | ,100:119:treatment | Unresolved toxicity > Common Terminology Criteria for Adverse Events (CTCAE) grade 2 from previous anti-cancer therapy | 2 | [
"Unresolved",
"toxicity",
">",
"Common",
"Terminology",
"Criteria",
"for",
"Adverse",
"Events",
"(",
"CTCAE",
")",
"grade",
"2",
"from",
"previous",
"anti-cancer",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02412540 | 1:15:chronic_disease | Wilson disease | 2 | [
"Wilson",
"disease"
] | [
2,
2
] |
NCT02837497 | 14:36:treatment | AND Received CPR in the ICU setting | 2 | [
"AND",
"Received",
"CPR",
"in",
"the",
"ICU",
"setting"
] | [
0,
0,
1,
1,
1,
1,
1
] |
NCT03122691 | 12:34:chronic_disease,55:64:chronic_disease,66:91:chronic_disease | History of xerostomia (dry mouth), or the presence of mucositis, gum infection or bleeding, or other significant oral cavity disease or disorder that in the investigator's opinion may affect the collection of oral fluid samples | 2 | [
"History",
"of",
"xerostomia",
"(",
"dry",
"mouth",
")",
",",
"or",
"the",
"presence",
"of",
"mucositis",
",",
"gum",
"infection",
"or",
"bleeding",
",",
"or",
"other",
"significant",
"oral",
"cavity",
"disease",
"or",
"disorder",
"that",
"in",
"the",
"inv... | [
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02373644 | 1:7:cancer | tumors | 2 | [
"tumors"
] | [
3
] |
NCT00715611 | ,,42:72:cancer | at the participating site of stage I-III malignant pleural mesothelioma | 2 | [
"at",
"the",
"participating",
"site",
"of",
"stage",
"I-III",
"malignant",
"pleural",
"mesothelioma"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
3
] |
NCT02520011 | 12:46:treatment, | Received a hematopoietic stem cell transplant within the previous 2 months | 2 | [
"Received",
"a",
"hematopoietic",
"stem",
"cell",
"transplant",
"within",
"the",
"previous",
"2",
"months"
] | [
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT03015805 | 1:33:chronic_disease | Pervasive developmental disorder | 2 | [
"Pervasive",
"developmental",
"disorder"
] | [
2,
2,
2
] |
NCT03170453 | 36:56:chronic_disease | Presence of significant social and cognitive disability, based on the Cognitive Style and Social Cognition Eligibility Interview (Hogarty et al., 2004) | 2 | [
"Presence",
"of",
"significant",
"social",
"and",
"cognitive",
"disability",
",",
"based",
"on",
"the",
"Cognitive",
"Style",
"and",
"Social",
"Cognition",
"Eligibility",
"Interview",
"(",
"Hogarty",
"et",
"al.",
",",
"2004",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02977468 | 9:41:cancer,43:78:cancer,80:98:cancer,106:126:cancer,158:174:treatment | include basal cell carcinoma of the skin, squamous cell carcinoma of the skin, DCIS of the breast, or in situ cervical cancer that has undergone potentially curative therapy | 2 | [
"include",
"basal",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin",
",",
"DCIS",
"of",
"the",
"breast",
",",
"or",
"in",
"situ",
"cervical",
"cancer",
"that",
"has",
"undergone",
"potentially",
"curative",... | [
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
0,
3,
3,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
1,
1
] |
NCT01670877 | 56:72:treatment | There is no limitation on the number of prior lines of systemic therapy | 2 | [
"There",
"is",
"no",
"limitation",
"on",
"the",
"number",
"of",
"prior",
"lines",
"of",
"systemic",
"therapy"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01061515 | 73:91:treatment | Intraperitoneal ports may be placed during or at any time separate from surgical debulking | 2 | [
"Intraperitoneal",
"ports",
"may",
"be",
"placed",
"during",
"or",
"at",
"any",
"time",
"separate",
"from",
"surgical",
"debulking"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03028350 | 32:38:chronic_disease | History of physician-diagnosed asthma | 2 | [
"History",
"of",
"physician-diagnosed",
"asthma"
] | [
0,
0,
0,
2
] |
NCT03033888 | 1:14:chronic_disease | HIV infection | 2 | [
"HIV",
"infection"
] | [
2,
2
] |
NCT02109081 | ,,65:90:chronic_disease | MMSE score of ≤ 20 out of 30 on preoperative testing (more than mild cognitive impairment) or delirium on preoperative CAM testing | 2 | [
"MMSE",
"score",
"of",
"≤",
"20",
"out",
"of",
"30",
"on",
"preoperative",
"testing",
"(",
"more",
"than",
"mild",
"cognitive",
"impairment",
")",
"or",
"delirium",
"on",
"preoperative",
"CAM",
"testing"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT03186872 | 1:30:chronic_disease | Personality pathology or PTSD (captured from DSM-V cross cutting symptoms inventory already being used as part of routine care screening in this clinic) | 2 | [
"Personality",
"pathology",
"or",
"PTSD",
"(",
"captured",
"from",
"DSM-V",
"cross",
"cutting",
"symptoms",
"inventory",
"already",
"being",
"used",
"as",
"part",
"of",
"routine",
"care",
"screening",
"in",
"this",
"clinic",
")"
] | [
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03006770 | 1:18:chronic_disease,, | Diabetes mellitus with HbA1c >10% | 2 | [
"Diabetes",
"mellitus",
"with",
"HbA1c",
">",
"10",
"%"
] | [
2,
2,
0,
0,
0,
0,
0
] |
NCT01627821 | 33:46:chronic_disease, | Clinical conditions, other than heart failure, which could limit survival to less than three years | 2 | [
"Clinical",
"conditions",
",",
"other",
"than",
"heart",
"failure",
",",
"which",
"could",
"limit",
"survival",
"to",
"less",
"than",
"three",
"years"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02091141 | 1:25:treatment,,95:104:treatment,136:160:treatment | Major surgical procedure other than for diagnosis within 4 weeks prior to initiation of study treatment, or anticipation of need for a major surgical procedure during the course of the study | 2 | [
"Major",
"surgical",
"procedure",
"other",
"than",
"for",
"diagnosis",
"within",
"4",
"weeks",
"prior",
"to",
"initiation",
"of",
"study",
"treatment",
",",
"or",
"anticipation",
"of",
"need",
"for",
"a",
"major",
"surgical",
"procedure",
"during",
"the",
"cou... | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02489539 | 13:25:chronic_disease | Patient has body habitus or other medical condition which prevents adequate delineation of the aorta | 2 | [
"Patient",
"has",
"body",
"habitus",
"or",
"other",
"medical",
"condition",
"which",
"prevents",
"adequate",
"delineation",
"of",
"the",
"aorta"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02562235 | 1:19:chronic_disease | Hereditable (HPAH) | 2 | [
"Hereditable",
"(",
"HPAH",
")"
] | [
2,
2,
0,
0
] |
NCT02901314 | 38:49:chronic_disease,61:69:chronic_disease,71:84:chronic_disease,92:104:chronic_disease | adhere to self-care recommendations (Alzheimer's condition, dementia, schizophrenia, other neurological history that impairs memory) | 2 | [
"adhere",
"to",
"self-care",
"recommendations",
"(",
"Alzheimer",
"'s",
"condition",
",",
"dementia",
",",
"schizophrenia",
",",
"other",
"neurological",
"history",
"that",
"impairs",
"memory",
")"
] | [
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2,
2
] |
NCT02152956 | 25:37:treatment,39:61:treatment,66:90:treatment, | Previous treatment with radiotherapy, cytotoxic chemotherapy, or immunotherapeutic agents in the 4 weeks prior to study drug administration (Cycle 1 Day 1) | 2 | [
"Previous",
"treatment",
"with",
"radiotherapy",
",",
"cytotoxic",
"chemotherapy",
",",
"or",
"immunotherapeutic",
"agents",
"in",
"the",
"4",
"weeks",
"prior",
"to",
"study",
"drug",
"administration",
"(",
"Cycle",
"1",
"Day",
"1",
")"
] | [
0,
0,
0,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02570984 | 1:27:chronic_disease | major congenital anomalies | 2 | [
"major",
"congenital",
"anomalies"
] | [
2,
2,
2
] |
NCT02864147 | 1:31:chronic_disease | renal or hepatic insufficiency | 2 | [
"renal",
"or",
"hepatic",
"insufficiency"
] | [
2,
2,
2,
2
] |
NCT02687906 | 25:40:chronic_disease,73:94:chronic_disease,98:120:chronic_disease | Evidence of significant hepatic disease or dysfunction, including known acute viral hepatitis or hepatic encephalopathy | 2 | [
"Evidence",
"of",
"significant",
"hepatic",
"disease",
"or",
"dysfunction",
",",
"including",
"known",
"acute",
"viral",
"hepatitis",
"or",
"hepatic",
"encephalopathy"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0
] |
NCT02776059 | 7:20:chronic_disease | Known HIV infection | 2 | [
"Known",
"HIV",
"infection"
] | [
0,
2,
2
] |
NCT01087294 | 26:51:treatment | A trial of withdrawal of immunosuppressive therapy | 2 | [
"A",
"trial",
"of",
"withdrawal",
"of",
"immunosuppressive",
"therapy"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT01804465 | 14:132:treatment | A history of prior treatment with ipilimumab or prior cluster of differentiation 137 (CD137) agonist or CTLA-4 inhibitor or agonist | 2 | [
"A",
"history",
"of",
"prior",
"treatment",
"with",
"ipilimumab",
"or",
"prior",
"cluster",
"of",
"differentiation",
"137",
"(",
"CD137",
")",
"agonist",
"or",
"CTLA-4",
"inhibitor",
"or",
"agonist"
] | [
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0
] |
NCT03028831 | 1:19:chronic_disease | bleeding disorders | 2 | [
"bleeding",
"disorders"
] | [
2,
2
] |
NCT01570998 | 1:14:cancer | Node positive patients | 2 | [
"Node",
"positive",
"patients"
] | [
3,
3,
0
] |
NCT00919503 | 382:399:treatment | DONOR: HLA-matched sibling cord blood exclusions: Any cord blood units that have not passed donor screening for infectious disease markers as recommended by the National Marrow Donor Project (NMDP) will not be used unless a waiver is signed by the clinical attending allowing use of cord blood unit; cord blood units are... | 2 | [
"DONOR",
":",
"HLA-matched",
"sibling",
"cord",
"blood",
"exclusions",
":",
"Any",
"cord",
"blood",
"units",
"that",
"have",
"not",
"passed",
"donor",
"screening",
"for",
"infectious",
"disease",
"markers",
"as",
"recommended",
"by",
"the",
"National",
"Marrow",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT03032432 | 13:52:chronic_disease | Evidence of symptomatic glenohumeral osteoarthritis | 2 | [
"Evidence",
"of",
"symptomatic",
"glenohumeral",
"osteoarthritis"
] | [
0,
0,
2,
2,
2
] |
NCT02177695 | 23:37:cancer | Histologically proven bladder cancer | 2 | [
"Histologically",
"proven",
"bladder",
"cancer"
] | [
0,
0,
3,
3
] |
NCT02519348 | 16:28:treatment,30:43:treatment,48:76:treatment,81:87:cancer,88:97:treatment | Any concurrent chemotherapy, immunotherapy, or biologic or hormonal therapy for cancer treatment | 2 | [
"Any",
"concurrent",
"chemotherapy",
",",
"immunotherapy",
",",
"or",
"biologic",
"or",
"hormonal",
"therapy",
"for",
"cancer",
"treatment"
] | [
0,
0,
1,
0,
1,
0,
0,
1,
1,
1,
1,
0,
3,
1
] |
NCT01543490 | 15:31:chronic_disease,33:42:chronic_disease,44:49:chronic_disease,53:59:chronic_disease,71:90:chronic_disease,102:113:chronic_disease | Have an acute ocular infection (bacterial, viral or fungal) or active ocular inflammation other than blepharitis in the study eye | 2 | [
"Have",
"an",
"acute",
"ocular",
"infection",
"(",
"bacterial",
",",
"viral",
"or",
"fungal",
")",
"or",
"active",
"ocular",
"inflammation",
"other",
"than",
"blepharitis",
"in",
"the",
"study",
"eye"
] | [
0,
0,
0,
2,
2,
0,
2,
0,
2,
0,
2,
0,
0,
0,
0,
0,
0,
0,
2,
0,
0,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.